Clinical Trial Update: Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intrasphincteric autologous myoblast injections for stress urinary incontinence has completed, assessing safety and effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stress Urinary Incontinence

Drugs mentioned

• Autologous myoblast injection (intrasphincteric)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Stress Urinary Incontinence | Phase 1, Phase 2 | Status: COMPLETED